These success, along with a preceding report demonstrating that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like conduct in mice,2 assistance the strategy of concentrating on ACKR3 as a novel strategy to modulate the opioid method, which could open up new therapeutic avenues for opioid-linked Diseases.These success propose that conoli